Renalyse has successfully closed an investment round of 1 M€ in public and private capita... 09/10/2023 Access to innovation Financing The operation was led by the Mind the Gap program from Botín Foundation, with participation from GENESIS Ventures and... Partners - GENESIS Biomed
ADmit therapeutics closes a €5.4 million funding round led by Clave Capital, through its C... 05/10/2023 Financing The European Innovation Council (EIC) Fund and the Alzheimer's Drug Discovery Foundation (ADDF) Diagnostic Accelerator... Partners - ADmit Therapeutics
#BIOSPAIN2023Interview | "The biotechnology sector is in full expansion" 22/09/2023 BioSpain Financing More than 100 investors will gather at BIOSPAIN 2023, an international benchmark event in the biotechnology sector... AseBio
#BIOSPAIN2023 Interview | "Entrepreneurial activity in Spain is lower, but more resilient ... 13/09/2023 BioSpain Financing We analyze Spain's entrepreneurial capacity under the brand Spain Up Nation, an initiative of the Government of Spain... AseBio
#BIOSPAIN2023Interview | "Biotech SMEs focus on projects with no mid-term cash generation,... 13/09/2023 BioSpain Financing We discuss the launch of BME Scale, a new market primarily aimed at "scale-ups," with Jesús González, Managing Director... AseBio - BME Growth
#BIOSPAIN2023Interview | "The 'biotech' sector is one of the sectors with the greatest fin... 12/09/2023 BioSpain Financing We spoke with Cristina Cortés, manager at Ayming, Bronze Sponsor of BIOSPAIN 2023, about the role of private financing... AseBio - Ayming
Barcelona Science Park companies break record after raising €142M in 2022 23/08/2023 Healthcare Access to innovation Financing 2022 has been a historic year in economic and innovation indicators for the ecosystem of companies that form part of the... Partners - Parc Científic de Barcelona
Orikine Bio closes €5.5m Series Seed Financing with Sabadell Asabys and AdBio 18/07/2023 Financing Corporate New synthetic biology spin-off from the Centre for Genomic Regulation (CRG) in Barcelona developing a novel proprietary... Partners - Asabys Partners
VIVEbiotech participates in the European MAGIC project 11/07/2023 Healthcare Personalized medicine Advanced therapies Gene editing International EU projects Financing VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is... Partners - VIVEbiotech
Biotech companies’ R&D investment grows by 16% in 2022 to reach €1,038 million 20/06/2023 Healthcare Advanced therapies Agrifood Financing In 2021, the impact on GDP of biotech companies amounted to €11,183 million, or 1% of GDP AseBio
